Rheumatoid arthritis: Seropositivity versus seronegativity; A comparative cross-sectional study arising from Moroccan context.
Rheumatoid arthritis (RA) is biologically marked by a positive serum rate of rheumatoid factor (RA) and/or anti-citrullinated protein antibodies (ACPA). Nevertheless, 20% of RA cases remain seronegative. The main purpose of this study, is to bring out the clinical, biological, imaging, therapeutic, and evolutionary distinctions between seropositive RA and seronegative one. This is an observational cross-sectional study that involves the whole patients with RA admitted within our rheumatology department, all along the period lying between january 2012 and january 2018. RA seronegativity is described as the absence of both RF and ACPA , while seropositivity is recognized by the presence of at least one of the two antibodies. 294 patients were included, of which 90% were seropositive and 10% seronegative. Thereby, RA in our study is most often seropositive. The bivariate analysis underscored plenty of differences, statistically notable, according to the RA immune status. In fact, patients with seropositive RA had more synovitis (p=0.049), more deformities (p=0.01), and more bone destruction on radiographs (p=0.04). Furthermore, RA in this Moroccan study tended to be quite severe (p=0.006) and got more complicated by systemic manifestations (p=0.02). Whereas, no distinction was brought up between the two groups, concerning the resort to biotherapy. As for the multivariate study, RA in our patients, had greater severity (p=0.009, OR=4.53) and was more deforming (p=0.03 OR=2.45). RA in our Moroccan context is dominated by the seropositive form. This seropositivity is often coupled with clinical severity and joint destruction, resulting in more deformities.